France will ask EU to curb use of newer birth control pills

PARIS (Reuters) – French health authorities will ask the European Union to restrict the use of newer types of contraceptive pills over concerns they might carry health risks. France’s health minister Marisol Touraine said on Friday the newer pills, which have caught on because they reduce side effects from earlier versions such as weight gain and acne, should only be prescribed by specialist doctors to women who cannot use other types of contraception. …

EU agency sees no new risks with combined contraceptives

LONDON (Reuters) – European drug regulators said on Friday there was no reason for women to stop using combined contraceptives like Bayer’s Meliane or Yasmin pills since there was no new evidence pointing to safety risks. The move comes after French health regulators said last week they were considering limiting use of some birth control pills after a woman sued the German drugmaker over alleged side-effects. …

Ireland to revamp abortion laws after woman’s death

A woman holds a poster during a vigil in Dublin in memory of Savita Halappanavar and in support of changes to abortion law. The 31 year old died at a Galway hospital last month. Her family claim she was repeatedly refused a termination during a miscarriageDUBLIN (Reuters) – Laws allowing limited access to abortion will be introduced in Ireland, the only EU member state that bans the procedure, following the death of a woman who was refused a termination, the government said on Tuesday. The death last month of 31-year-old Savita Halappanavar, who was denied an abortion of her dying fetus and later died of blood poisoning, shocked the predominantly Roman Catholic country and spurred the government to act on an issue it had delayed for decades. …

Novo Nordisk wins EU agency backing for new insulin

LONDON/COPENHAGEN (Reuters) – Novo Nordisk’s ultra long-acting insulin Tresiba has been recommended for approval by the European Medicines Agency in an important boost for the Danish drugmaker’s key new product. The European endorsement, announced by the London-based agency and the company on Friday, follows regulatory delays for the diabetes treatment in the United States, where the bulk of future sales are expected to be generated. …

EU regulators charge Lundbeck, others over generics

BRUSSELS (Reuters) – EU antitrust regulators charged Danish drugmaker Lundbeck, German peer Merck and seven other firms with blocking the entry of cheaper generic medicines into the market in a move that could lead to fines for the companies. The European Commission said on Wednesday the tactic breached EU antitrust rules. It also warned of further action against French drugmaker Servier and several generic rivals in the coming days for a similar offence, related to another medicine. Reuters had reported on Tuesday that the EU watchdog would act against Lundbeck and Servier. …

1 2 3